|
|
|
1
|
Sloand EM, Scheinberg P, Maciejewski J, Young NS.
Brief communication: successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab).
Ann Intern Med 144(3): 181-5, 2006.
[Text Abstract on PubMed]
|
|
|
2
|
Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, Philip McCoy J, Sloand EM, Kajigaya S, Young NS.
Hematopoietic-specific microRNA expression in human cells.
Leuk Res: 2005.
[Text Abstract on PubMed]
|
|
|
3
|
Ramkissoon SH, Mainwaring LA, Sloand EM, Young NS, Kajigaya S.
Nonisotopic detection of microRNA using digoxigenin labeled RNA probes.
Mol Cell Probes: 2005.
[Text Abstract on PubMed]
|
|
|
4
|
Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, Lu J, Basu A, Barrett AJ, Young NS.
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Blood 106(3): 841-51, 2005.
[Text Abstract on PubMed]
|
|
|
5
|
Sloand EM.
Soluble urokinase activator receptor (suPAR) in stem cell mobilization.
Blood 105(5): 1847-8, 2005.
[Text Abstract on PubMed]
|
|
|
6
|
Bagby GC, Lipton JM, Sloand EM, Schiffer CA.
Marrow failure.
Hematology (Am Soc Hematol Educ Program): 318-36, 2004.
[Text Abstract on PubMed]
|
|
|
7
|
Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS.
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
Blood 104(13): 4210-8, 2004.
[Text Abstract on PubMed]
|
|
|
8
|
Sloand EM, Mainwaring L, Keyvanfar K, Chen J, Maciejewski J, Klein HG, Young NS.
Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria.
Blood 104(12): 3782-8, 2004.
[Text Abstract on PubMed]
|
|
|
9
|
Maciejewski JP, Sloand EM, Nunez O, Boss C, Young NS.
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia.
Blood 102(10): 3584-6, 2003.
[Text Abstract on PubMed]
|
|
|
10
|
Sloand EM, Fuhrer M, Keyvanfar K, Mainwaring L, Maciejewski J, Wang Y, Johnson S, Barrett AJ, Young NS.
Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive.
Br J Haematol 123(1): 173-6, 2003.
[Text Abstract on PubMed]
|
|
|
11
|
Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE.
Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
Exp Hematol 30(8): 943-9, 2002.
[Text Abstract on PubMed]
|
|
|
12
|
Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS.
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Blood 99(9): 3129-35, 2002.
[Text Abstract on PubMed]
|
|
|
13
|
Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, Barrett JA, Young NS, Ristiano AM.
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
Br J Haematol 117(1): 119-26, 2002.
[Text Abstract on PubMed]
|
|
|
14
|
Sloand EM, Kim S, Fuhrer M, Risitano AM, Nakamura R, Maciejewski JP, Barrett AJ, Young NS.
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Blood 100(13): 4427-32, 2002.
[Text Abstract on PubMed]
|
|
|
15
|
Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS.
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
Blood 95(7): 2269-74, 2000.
[Text Abstract on PubMed]
|
|
|
16
|
Sloand EM, Maciejewski J, Kumar P, Kim S, Chaudhuri A, Young N.
Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells.
Blood 96(8): 2735-9, 2000.
[Text Abstract on PubMed]
|
|
|
17
|
Stiehm ER, Fletcher CV, Mofenson LM, Palumbo PE, Kang M, Fenton T, Sapan CV, Meyer WA, Shearer WT, Hawkins E, Fowler MG, Bouquin P, Purdue L, Sloand EM, Nemo GJ, Wara D, Bryson YJ, Starr SE, Petru A, Burchett S.
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
J Infect Dis 181(2): 548-54, 2000.
[Text Abstract on PubMed]
|
|
|
18
|
Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS.
Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
Blood 94(3): 1021-7, 1999.
[Text Abstract on PubMed]
|
|
|
19
|
Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS.
Correction of the PNH defect by GPI-anchored protein transfer.
Blood 92(11): 4439-45, 1998.
[Text Abstract on PubMed]
|
|
|
20
|
Sloand EM, Maciejewski JP, Sato T, Bruny J, Kumar P, Kim S, Weichold FF, Young NS.
The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection.
J Clin Invest 101(1): 195-201, 1998.
[Text Abstract on PubMed]
|
|
|
21
|
Sloand EM, Young NS, Sato T, Kim S, Maciejewski JP.
Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
Exp Hematol 26(11): 1093-9, 1998.
[Text Abstract on PubMed]
|
|
|
22
|
Weichold FF, Zella D, Barabitskaja O, Maciejewski JP, Dunn DE, Sloand EM, Young NS.
Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures.
Blood 91(3): 907-15, 1998.
[Text Abstract on PubMed]
|
|
|
23
|
Maciejewski JP, Sloand EM, Sato T, Anderson S, Young NS.
Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Blood 89(4): 1173-81, 1997.
[Text Abstract on PubMed]
|
|
|
24
|
Sloand EM, Groopman JE.
Transfusion in HIV disease.
Curr Opin Hematol 4(6): 449-54, 1997.
[Text Abstract on PubMed]
|
|
|
25
|
Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP.
Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.
Blood 89(4): 1357-63, 1997.
[Text Abstract on PubMed]
|
|
|
26
|
Sloand EM, Young NS, Sato T, Kumar P, Kim S, Weichold FF, Maciejewski JP.
Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients.
AIDS 11(13): 1547-53, 1997.
[Text Abstract on PubMed]
|
|
|
27
|
Sloand EM.
Viral risks associated with blood transfusion.
Photochem Photobiol 65(3): 428-31, 1997.
[Text Abstract on PubMed]
|
|
|
28
|
Sloand JA, Sloand EM.
Studies on platelet membrane glycoproteins and platelet function during hemodialysis.
J Am Soc Nephrol 8(5): 799-803, 1997.
[Text Abstract on PubMed]
|
|
|
29
|
Maciejewski JP, Young NS, Yu M, Anderson SM, Sloand EM.
Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Thromb Res 83(6): 433-47, 1996.
[Text Abstract on PubMed]
|
|
|
30
|
Sloand EM, Pitt E, Klein HG.
Safety of the blood supply.
JAMA 274(17): 1368-73, 1995.
[Text Abstract on PubMed]
|
|
|
31
|
Sloand EM, Alyono D, Klein HG, Chang P, Yu M, Lightfoot FG, Kessler C.
1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass.
Am J Hematol 46(3): 199-207, 1994.
[Text Abstract on PubMed]
|
|
|
32
|
Sloand EM, Kumar P, Yu M, Klein HG.
Effect of amphotericin B and fluconazole on platelet membrane glycoproteins.
Transfusion 34(5): 415-20, 1994.
[Text Abstract on PubMed]
|
|
|
33
|
Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P.
Epidemiology of thrombocytopenia in HIV infection.
Eur J Haematol 48(3): 168-72, 1992.
[Text Abstract on PubMed]
|
|
|
34
|
Sloand EM, Klein HG, Pastakia KB, Pierce P, Prodouz KN.
Effect of albumin on the inhibition of platelet aggregation by beta-lactam antibiotics.
Blood 79(8): 2022-7, 1992.
[Text Abstract on PubMed]
|
|
|
35
|
Sloand EM, Pitt E, Chiarello RJ, Nemo GJ.
HIV testing. State of the art.
JAMA 266(20): 2861-6, 1991.
[Text Abstract on PubMed]
|
|
|
36
|
Sloand EM, Sloand JA, Prodouz K, Klein HG, Yu MW, Harvath L, Fricke W.
Reduction of platelet glycoprotein Ib in uraemia.
Br J Haematol 77(3): 375-81, 1991.
[Text Abstract on PubMed]
|
|
|
37
|
Sloand EM, Fox SM, Banks SM, Klein HG.
Preparation of IgA-deficient platelets.
Transfusion 30(4): 322-6, 1990.
[Text Abstract on PubMed]
|
|
|
38
|
Sloand EM, Klein HG.
Effect of white cells on platelets during storage.
Transfusion 30(4): 333-8, 1990.
[Text Abstract on PubMed]
|
|
|
39
|
Sloand EM, Kessler CM, McIntosh CL, Klein HG.
Methylene blue for neutralization of heparin.
Thromb Res 54(6): 677-86, 1989.
[Text Abstract on PubMed]
|
|
|
40
|
Sloand EM, Kenney DM, Chao FC, Lawler J, Tullis JL.
Platelet antithrombin defect in malignancy: platelet protein alterations.
Blood 69(2): 479-85, 1987.
[Text Abstract on PubMed]
|
|
|
41
|
Sloand EM, Bern MM, Kaldany A.
Effect on platelet function of hypoalbuminemia in peritoneal dialysis.
Thromb Res 44(4): 419-25, 1986.
[Text Abstract on PubMed]
|
|
|
42
|
Sloand EM, Thompson BT.
Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma.
Arch Intern Med 144(1): 173-4, 1984.
[Text Abstract on PubMed]
|
|
|
43
|
Sloand EM, Klein HG, Fox S.
IgA levels in platelets washed by automated procedure.
Transfusion 28(3): 291,
[Text Abstract on PubMed]
|
|
|
44
|
Sloand EM, Yu M, Klein HG.
Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
Transfusion 36(11-12): 955-9,
[Text Abstract on PubMed]
|
|
|